BANRBanner CorporationMid cap · $2.33B · TTM ending 2026-03-31
$68.57+1.46% · 2026-07-13 · EOD
47/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality19
thin moat · ROIC 4%Value61
P/E 12.2 · 93% of 12-mo rangeMomentum60
golden · price above 200-daySmart Money50
quiet · 0 funds · 0P/0S insidersBullish stackGolden crossAbove 200-day
vs S&P 500-3.7%
6-mo excess Trailing performance1M +3.1%
3M +7.2%
6M +5.0%
YTD +9.8%
1Y -0.2%
P/E vs its last 12 months (our price history): 10.3 low → 12.3 high
Current price sits at the 93th percentile of that window — near the top (richer). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
No clear moat — ROIC 4%
ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of ~21%. Trailing-twelve-month figures from SEC XBRL.
Dividend & capital return
Payout ratio32.9%
comfortable Shareholder yield4.3%
dividends + buybacks Trailing figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Quiet0P / 0S insiders · 0 funds hold · 0 Congress buys
No recent insider, Congress, or fund activity on file for BANR.
Bhealth · 75/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.